BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Cromsource Acquires Pleiad Devices - Expands US Coverage


6/1/2012 11:10:59 AM

VERONA, Italy, June 1, 2012 -- /PRNewswire/ -- CROMSOURCE, an international full service contract research organisation (CRO) today announced the acquisition of Pleiad, an established international CRO with offices in the US (Cambridge, Mass.) and UK (Stirling, Scotland).

Pleiad was launched in 1999, supporting clients in multiple therapy areas and with dedicated Medical Device and Ophthalmology Divisions. Additionally, Pleiad also encompasses particularly strong capabilities within statistics and data management.

'We are delighted to welcome Pleiad and its expert team', stated Dr Oriana Zerbini, Chief Executive Officer of CROMSOURCE. 'For some time we have wanted to expand and consolidate our presence in the US and we have now found the perfect way to do so. The opportunity to further add to our UK team and expand our team of experts in data management and statistics is also of great importance to us. With this collaboration CROMSOURCE reinforces its capability to support our clients with even the largest of development programmes in both Europe and the USA.'

Dr Helen Colquhoun, CEO of Pleiad, noted 'with CROMSOURCE we share a philosophy of quality, flexibility and intense customer focus. We are therefore very excited to be joining the CROMSOURCE family and working together to provide exceptional service to our current and future clients.'

About CROMSOURCE: CROMSOURCE is an ISO certified, full-service Contract Research Organization providing clinical trial services and staffing solutions since 1994. CROMSOURCE delivers clinical trials across Europe, Russia, Ukraine and the USA and operates a high quality early phase unit. CROMSOURCE provides One Trial One Price - a fixed price guarantee which assures clients that each project will be delivered according to the contract price.

President of CROMSOURCE Group will be Dr. Oriana Zerbini, and Dr. Helen Colquhoun, former President of Pleiad will become Senior Vice President of CROMSOURCE Inc.

Contact: Margherita Mosconi CROMSOURCE Phone: +39-045-8222811 Fax: +39-045-8222812 Via Scuderlando, 10 37135 Verona, Italy

http://www.cromsource.com

SOURCE CROMSOURCE


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->